[go: up one dir, main page]

CY2020015I2 - Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα - Google Patents

Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Info

Publication number
CY2020015I2
CY2020015I2 CY2020015C CY2020015C CY2020015I2 CY 2020015 I2 CY2020015 I2 CY 2020015I2 CY 2020015 C CY2020015 C CY 2020015C CY 2020015 C CY2020015 C CY 2020015C CY 2020015 I2 CY2020015 I2 CY 2020015I2
Authority
CY
Cyprus
Prior art keywords
ciclesonide
horses
treatment
airway disease
airway
Prior art date
Application number
CY2020015C
Other languages
English (en)
Other versions
CY2020015I1 (el
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2020015(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY2020015I1 publication Critical patent/CY2020015I1/el
Publication of CY2020015I2 publication Critical patent/CY2020015I2/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
CY2020015C 2012-12-21 2020-06-29 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα CY2020015I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13811924.3A EP2934479B1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (2)

Publication Number Publication Date
CY2020015I1 CY2020015I1 (el) 2020-11-25
CY2020015I2 true CY2020015I2 (el) 2021-03-12

Family

ID=47552829

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181101189T CY1121115T1 (el) 2012-12-21 2018-11-09 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
CY2020015C CY2020015I2 (el) 2012-12-21 2020-06-29 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY181101189T CY1121115T1 (el) 2012-12-21 2018-11-09 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Country Status (24)

Country Link
US (4) US20140179651A1 (el)
EP (1) EP2934479B1 (el)
AR (1) AR094241A1 (el)
AU (2) AU2013360691B2 (el)
BR (2) BR122016029247A2 (el)
CA (1) CA2888428C (el)
CY (2) CY1121115T1 (el)
DK (1) DK2934479T3 (el)
ES (1) ES2693779T3 (el)
FR (1) FR20C1026I1 (el)
HR (1) HRP20181980T1 (el)
HU (1) HUS2000020I1 (el)
IN (1) IN2015DN02894A (el)
LT (2) LT2934479T (el)
MA (1) MA38169B2 (el)
MX (1) MX368306B (el)
NO (1) NO2020014I1 (el)
NZ (1) NZ706573A (el)
PL (1) PL2934479T3 (el)
PT (1) PT2934479T (el)
RS (1) RS57740B1 (el)
SI (1) SI2934479T1 (el)
WO (1) WO2014096115A1 (el)
ZA (1) ZA201502288B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103781468A (zh) 2011-08-12 2014-05-07 勃林格殷格翰动物保健有限公司 治疗及预防猫科动物心脏衰竭的方法中所用的起搏电流(If)抑制剂
LT2934479T (lt) 2012-12-21 2018-12-27 Boehringer Ingelheim Vetmedica Gmbh Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
IN2015DN02999A (el) 2012-12-21 2015-09-25 Boehringer Ingelheim Vetmed
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih
WO2018070819A1 (ko) * 2016-10-14 2018-04-19 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
US20230033224A1 (en) 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
MX2023001201A (es) 2020-07-31 2023-05-03 Chemo Res S L Terapia combinada para la administracion por inhalacion.

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US20040053902A1 (en) 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
JP2006528228A (ja) 2003-05-22 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (en) 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
JP2008504341A (ja) 2004-06-29 2008-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドと抗コリン作用剤とを含む吸入用薬剤
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US9084660B2 (en) 2009-06-25 2015-07-21 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US20150202148A1 (en) 2012-07-05 2015-07-23 Arven llac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
IN2015DN02999A (el) 2012-12-21 2015-09-25 Boehringer Ingelheim Vetmed
LT2934479T (lt) 2012-12-21 2018-12-27 Boehringer Ingelheim Vetmedica Gmbh Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
KR102456231B1 (ko) 2013-08-20 2022-10-20 베링거잉겔하임베트메디카게엠베하 흡입기
NZ714524A (en) 2013-08-20 2020-07-31 Boehringer Ingelheim Vetmedica Gmbh Inhaler
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih

Also Published As

Publication number Publication date
RS57740B1 (sr) 2018-12-31
BR112015010842B1 (pt) 2021-03-30
CY2020015I1 (el) 2020-11-25
MA38169A1 (fr) 2017-01-31
BR112015010842A8 (pt) 2019-10-01
AU2013360691A1 (en) 2015-04-16
BR112015010842A2 (pt) 2017-07-11
AU2018201642A1 (en) 2018-03-29
PT2934479T (pt) 2018-12-20
DK2934479T3 (en) 2018-11-05
US20170079988A1 (en) 2017-03-23
EP2934479A1 (en) 2015-10-28
US10258634B2 (en) 2019-04-16
SI2934479T1 (sl) 2019-01-31
AU2018201642B2 (en) 2019-01-31
HUS2000020I1 (hu) 2020-07-28
MA38169B2 (fr) 2021-08-31
EP2934479B1 (en) 2018-09-19
NZ706573A (en) 2019-11-29
BR122016029247A2 (pt) 2019-08-20
US20150313918A1 (en) 2015-11-05
LT2934479T (lt) 2018-12-27
US10441597B2 (en) 2019-10-15
NO2020014I1 (no) 2020-06-12
AU2013360691B2 (en) 2018-03-08
MX2015007947A (es) 2015-10-08
US20180153907A1 (en) 2018-06-07
HRP20181980T1 (hr) 2019-01-25
FR20C1026I1 (fr) 2020-10-02
ZA201502288B (en) 2019-09-25
PL2934479T3 (pl) 2019-02-28
ES2693779T3 (es) 2018-12-13
US9918995B2 (en) 2018-03-20
CA2888428A1 (en) 2014-06-26
US20140179651A1 (en) 2014-06-26
CY1121115T1 (el) 2019-12-11
LTPA2020511I1 (lt) 2020-07-27
IN2015DN02894A (el) 2015-09-11
CA2888428C (en) 2021-07-13
MX368306B (es) 2019-09-27
WO2014096115A1 (en) 2014-06-26
AR094241A1 (es) 2015-07-22

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
IL285843A (en) Ibrutinib for use in the treatment of chronic graft versus host disease
CY2020015I2 (el) Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
HK1200872A1 (en) Animal models and therapeutic molecules
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2863990T3 (da) Medicinsk mikroelektrode
IL237592B (en) Methods of expanding and assessing b cells and using expanded b cells to treat disease
EP2935229A4 (en) Esterification of 2,5-Furan-Dicarboxylic Acid
EP2906208A4 (en) THERAPEUTIC TREATMENT
HK1211210A1 (zh) 治療多發性硬化症的組合療法
EP2913047A4 (en) SPECIFIC THERAPEUTIC AGENT OF PULMONARY DISEASE
EP3794941C0 (en) ANIMAL MODELS AND THERAPEUTIC MOLECULES
DK3335652T3 (da) Medicinsk fastgørelseselement
EP2872120A4 (en) TARGETED THERAPEUTIC NANOPARTICLES
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
HUE053561T2 (hu) Állatõrzõ kerítés és eljárás annak összeszerelésére
BR112014009789A2 (pt) cisteamina no tratamento da doença fibrótica
BR112014026557A2 (pt) fralda descartável.
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
IL227747A0 (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
BR112014030277A2 (pt) sistema médico
LT2958624T (lt) Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas
EP2931176A4 (en) Medical sling